Búsqueda | Portal de Búsqueda de la BVS España

1.

Synthesis and Evaluation of Glycosyl Luciferins.

Sondag, Daan; de Kleijne, Frank F J; Castermans, Sam; Chatzakis, Isa; van Geffen, Mark; Van't Veer, Cornelis; van Heerde, Waander L; Boltje, Thomas J; Rutjes, Floris P J T.

Chemistry; 30(3): e202302547, 2024 Jan 11.

Artículo en Inglés | MEDLINE | ID: mdl-37849395

2.

Solid-Phase Synthesis of Caged Luminescent Peptides via Side Chain Anchoring.

Sondag, Daan; Heming, Jurriaan J A; Löwik, Dennis W P M; Krivosheeva, Elena; Lejeune, Denise; van Geffen, Mark; Van't Veer, Cornelis; van Heerde, Waander L; Beens, Marjolijn C J; Kuijpers, Brian H M; Boltje, Thomas J; Rutjes, Floris P J T.

Bioconjug Chem; 34(12): 2234-2242, 2023 12 20.

Artículo en Inglés | MEDLINE | ID: mdl-38055970

3.

Activity Sensing of Coagulation and Fibrinolytic Proteases.

Sondag, Daan; Verhoeven, Stijn; Löwik, Dennis W P M; van Geffen, Mark; Veer, Cornelis Van't; van Heerde, Waander L; Boltje, Thomas J; Rutjes, Floris P J T.

Chemistry; 29(18): e202203473, 2023 Mar 28.

Artículo en Inglés | MEDLINE | ID: mdl-36484562

4.

Luminescent Assay for the Screening of SARS-CoV-2 M^Pro Inhibitors.

Sondag, Daan; Merx, Jona; Rossing, Emiel; Boltje, Thomas J; Löwik, Dennis W P M; Nelissen, Frank H T; van Geffen, Mark; van 't Veer, Cornelis; van Heerde, Waander L; Rutjes, Floris P J T.

Chembiochem; 23(15): e202200190, 2022 08 03.

Artículo en Inglés | MEDLINE | ID: mdl-35649961

5.

Diagnosis of rare bleeding disorders.

Meijer, Karina; van Heerde, Waander; Gomez, Keith.

Haemophilia; 28 Suppl 4: 119-124, 2022 May.

Artículo en Inglés | MEDLINE | ID: mdl-35521730

6.

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A.

Bukkems, Laura H; Valke, Lars L F G; Barteling, Wideke; Laros-van Gorkom, Britta A P; Blijlevens, Nicole M A; Cnossen, Marjon H; van Heerde, Waander L; Schols, Saskia E M; Mathôt, Ron A A.

Br J Clin Pharmacol; 88(6): 2757-2768, 2022 06.

Artículo en Inglés | MEDLINE | ID: mdl-34921439

7.

Diagnosis of rare bleeding disorders.

Meijer, Karina; van Heerde, Waander; Gomez, Keith.

Haemophilia; 27 Suppl 3: 60-65, 2021 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-32578312

8.

Diagnostic work up of patients with increased bleeding tendency.

Zegers, Suzanne A M; Smit, Yolba; Saes, Joline L; van Duren, Clint; Schuijt, Tim J; van Heerde, Waander L; Schols, Saskia E M.

Haemophilia; 26(2): 269-277, 2020 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-31886943

9.

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency.

Saes, Joline L; Schols, Saskia E M; Betbadal, Kathleen F; van Geffen, Mark; Verbeek-Knobbe, Kitty; Gupta, Sweta; Hardesty, Brandon M; Shapiro, Amy D; van Heerde, Waander L.

Haemophilia; 25(6): 1073-1082, 2019 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-31469483

10.

Whole exome sequencing in the diagnostic workup of patients with a bleeding diathesis.

Saes, Joline L; Simons, Annet; de Munnik, Sonja A; Nijziel, Marten R; Blijlevens, Nicole M A; Jongmans, Marjolijn C; van der Reijden, Bert A; Smit, Yolba; Brons, Paul P; van Heerde, Waander L; Schols, Saskia E M.

Haemophilia; 25(1): 127-135, 2019 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-30431218

11.

A dominant-negative GFI1B mutation in the gray platelet syndrome.

Monteferrario, Davide; Bolar, Nikhita A; Marneth, Anna E; Hebeda, Konnie M; Bergevoet, Saskia M; Veenstra, Hans; Laros-van Gorkom, Britta A P; MacKenzie, Marius A; Khandanpour, Cyrus; Botezatu, Lacramiora; Fransen, Erik; Van Camp, Guy; Duijnhouwer, Anthonie L; Salemink, Simone; Willemsen, Brigith; Huls, Gerwin; Preijers, Frank; Van Heerde, Waander; Jansen, Joop H; Kempers, Marlies J E; Loeys, Bart L; Van Laer, Lut; Van der Reijden, Bert A.

N Engl J Med; 370(3): 245-53, 2014 Jan 16.

Artículo en Inglés | MEDLINE | ID: mdl-24325358

12.

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.

van Bon, Lenny; Affandi, Alsya J; Broen, Jasper; Christmann, Romy B; Marijnissen, Renoud J; Stawski, Lukasz; Farina, Giuseppina A; Stifano, Giuseppina; Mathes, Allison L; Cossu, Marta; York, Michael; Collins, Cindy; Wenink, Mark; Huijbens, Richard; Hesselstrand, Roger; Saxne, Tore; DiMarzio, Mike; Wuttge, Dirk; Agarwal, Sandeep K; Reveille, John D; Assassi, Shervin; Mayes, Maureen; Deng, Yanhui; Drenth, Joost P H; de Graaf, Jacqueline; den Heijer, Martin; Kallenberg, Cees G M; Bijl, Marc; Loof, Arnoud; van den Berg, Wim B; Joosten, Leo A B; Smith, Vanessa; de Keyser, Filip; Scorza, Rafaella; Lunardi, Claudio; van Riel, Piet L C M; Vonk, Madelon; van Heerde, Waander; Meller, Stephan; Homey, Bernhard; Beretta, Lorenzo; Roest, Mark; Trojanowska, Maria; Lafyatis, Robert; Radstake, Timothy R D J.

N Engl J Med; 370(5): 433-43, 2014 Jan 30.

Artículo en Inglés | MEDLINE | ID: mdl-24350901

13.

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.

Eckhardt, Corien L; van Velzen, Alice S; Peters, Marjolein; Astermark, Jan; Brons, Paul P; Castaman, Giancarlo; Cnossen, Marjon H; Dors, Natasja; Escuriola-Ettingshausen, Carmen; Hamulyak, Karly; Hart, Daniel P; Hay, Charles R M; Haya, Saturnino; van Heerde, Waander L; Hermans, Cedric; Holmström, Margareta; Jimenez-Yuste, Victor; Keenan, Russell D; Klamroth, Robert; Laros-van Gorkom, Britta A P; Leebeek, Frank W G; Liesner, Ri; Mäkipernaa, Anne; Male, Christoph; Mauser-Bunschoten, Evelien; Mazzucconi, Maria G; McRae, Simon; Meijer, Karina; Mitchell, Michael; Morfini, Massimo; Nijziel, Marten; Oldenburg, Johannes; Peerlinck, Kathelijne; Petrini, Pia; Platokouki, Helena; Reitter-Pfoertner, Sylvia E; Santagostino, Elena; Schinco, Piercarla; Smiers, Frans J; Siegmund, Berthold; Tagliaferri, Annarita; Yee, Thynn T; Kamphuisen, Pieter Willem; van der Bom, Johanna G; Fijnvandraat, Karin.

Blood; 122(11): 1954-62, 2013 Sep 12.

Artículo en Inglés | MEDLINE | ID: mdl-23926300

14.

Effect of emicizumab on thrombin generation: A case report of breakthrough bleeding during emicizumab treatment.

Valke, Lars L F G; Beckers, Erik A M; Blijlevens, Nicole M A; van Heerde, Waander L; Schols, Saskia E M.

Haemophilia; 26(6): e327-e330, 2020 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-32596863

15.

Platelet CD34 expression and α/Î´-granule abnormalities in GFI1B- and RUNX1-related familial bleeding disorders.

Marneth, Anna E; van Heerde, Waander L; Hebeda, Konnie M; Laros-van Gorkom, Britta A P; Barteling, Wideke; Willemsen, Brigith; de Graaf, Aniek O; Simons, Annet; Jansen, Joop H; Preijers, Frank; Jongmans, Marjolijn C; van der Reijden, Bert A.

Blood; 129(12): 1733-1736, 2017 03 23.

Artículo en Inglés | MEDLINE | ID: mdl-28096094

16.

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.

Gouw, Samantha C; van den Berg, H Marijke; Oldenburg, Johannes; Astermark, Jan; de Groot, Philip G; Margaglione, Maurizio; Thompson, Arthur R; van Heerde, Waander; Boekhorst, Jorien; Miller, Connie H; le Cessie, Saskia; van der Bom, Johanna G.

Blood; 119(12): 2922-34, 2012 Mar 22.

Artículo en Inglés | MEDLINE | ID: mdl-22282501

17.

Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease.

Verhagen, Marieke J A; van Balen, Erna C; Blijlevens, Nicole M A; Coppens, Michiel; van Heerde, Waander L; Leebeek, Frank W G; Rijpma, Sanna R; van Vulpen, Lize F D; Gouw, Samantha C; Schols, Saskia E M.

J Thromb Haemost; 22(1): 152-162, 2024 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-37813197

18.

Pharmacokinetic-Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate.

Valke, Lars L F G; Cloesmeijer, Michael E; Mansouritorghabeh, Hassan; Barteling, Wideke; Blijlevens, Nicole M A; Cnossen, Marjon H; Mathôt, Ron A A; Schols, Saskia E M; van Heerde, Waander L.

Eur J Drug Metab Pharmacokinet; 49(2): 191-205, 2024 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-38367175

19.

The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.

Oomen, Ilja; Verhagen, Marieke; Miranda, Mariarosaria; Allacher, Peter; Beckers, Erik A M; Blijlevens, Nicole M A; van der Bom, Johanna G; Coppens, Michiel; Driessens, Mariëtte; Eikenboom, Jeroen C J; Fijnvandraat, Karin; Hassan, Shermarke; van Heerde, Waander L; Hooimeijer, H Louise; Jansen, Joop H; Kaijen, Paul; Leebeek, Frank W G; Meijer, Daniëlle; Paul, Helmut; Rijpma, Sanna R; Rosendaal, Frits R; Smit, Cees; van Vulpen, Lize F D; Voorberg, Jan; Schols, Saskia E M; Gouw, Samantha C.

Front Immunol; 15: 1355813, 2024.

Artículo en Inglés | MEDLINE | ID: mdl-38455035

20.

Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy.

Lappegård, Knut Tore; Pop-Purceleanu, Monica; van Heerde, Waander; Sexton, Joe; Tendolkar, Indira; Pop, Gheorghe.

J Neuroinflammation; 10: 78, 2013 Jun 28.

Artículo en Inglés | MEDLINE | ID: mdl-23809138

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Synthesis and Evaluation of Glycosyl Luciferins.

Solid-Phase Synthesis of Caged Luminescent Peptides via Side Chain Anchoring.

Activity Sensing of Coagulation and Fibrinolytic Proteases.

Luminescent Assay for the Screening of SARS-CoV-2 M^Pro Inhibitors.

Diagnosis of rare bleeding disorders.

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A.

Diagnosis of rare bleeding disorders.

Diagnostic work up of patients with increased bleeding tendency.

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency.

Whole exome sequencing in the diagnostic workup of patients with a bleeding diathesis.

A dominant-negative GFI1B mutation in the gray platelet syndrome.

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.

Effect of emicizumab on thrombin generation: A case report of breakthrough bleeding during emicizumab treatment.

Platelet CD34 expression and α/Î´-granule abnormalities in GFI1B- and RUNX1-related familial bleeding disorders.

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.

Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease.

Pharmacokinetic-Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate.

The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.

Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy.